TINA CAMPBELL: Open Payments
NPI 1326496357 · CLEVELAND, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 47 payments from 15 companies in 2025. Trend: 2023 $546 · 2024 $630 · 2025 $1,044
Food & beverage: $1,044
| Company | Payments | Amount |
|---|---|---|
| McKesson Drug Company LLC | 3 | $319 |
| Novo Nordisk Inc | 9 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $99 |
| Dexcom, Inc. | 3 | $79 |
| Amgen Inc. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| ABBVIE INC. | 3 | $52 |
| PFIZER INC. | 3 | $50 |
| Abbott Laboratories | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $35 |
Products named: CAPLYTA, Dexcom G6 Transmitter, Ozempic, Rybelsus, ELIQUIS, FREESTYLE LIBRE 3, FARXIGA, OTEZLA.
Industry payments across GA — which companies pay providers there.
